RNA

Prosensa Holding N.V. Press Releases

$9.15
*  
0.26
2.76%
Get RNA Alerts
*Delayed - data as of Aug. 28, 2014  -  Find a broker to begin trading RNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Prosensa Holding N.V. and a Lead Plaintiff Deadline of September 16, 2014 -- RNA
8/25/2014 6:57:00 PM - GlobeNewswire

Prosensa Announces 2nd Quarter 2014 Financial Results and Recent Corporate Developments
8/12/2014 7:00:00 AM - GlobeNewswire

CureDuchenne Announces $7 Million (€5M) Collaboration with Prosensa to Help Speed Access to Treatments for Duchenne Muscular Dystrophy Patients
8/11/2014 4:05:00 PM - Business Wire

Prosensa and CureDuchenne Strengthen Long-term Collaboration with an Additional [Eur]5M to Advance DMD Pipeline
8/11/2014 4:00:00 PM - GlobeNewswire

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014
8/11/2014 8:00:00 AM - Business Wire

Prosensa to Present at the Wedbush 2014 Life Sciences Conference
8/6/2014 8:00:00 AM - GlobeNewswire

Prosensa Holding N.V. to Webcast Conference Call Discussing 2nd Quarter 2014 Financial Results and Corporate Update on August 12, 2014
8/4/2014 8:00:00 AM - GlobeNewswire

PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Johnson & Weaver, LLP Reminds Investors of Upcoming September 16, 2014 Deadline; Encourages Investors with Significant Losses to Contact the Firm
7/26/2014 4:05:00 PM - Business Wire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prosensa N.V. - RNA
7/25/2014 4:33:00 PM - PR Newswire

Attention Prosensa Holding N.V. Investors: Prosensa Holding Misled Investors According to a Recently Filed Class Action
7/22/2014 2:34:00 PM - PR Newswire

Prosensa Holding - National Securities Law Firm Encourages Shareholders to Contact Law Firm Before Lead Plaintiff Deadline
7/21/2014 11:45:00 AM - PR Newswire

Prosensa Files F-3 SEC Mixed Shelf Registration For Up To $150 Million
7/7/2014 1:58:00 PM - GlobeNewswire

Prosensa Strengthens its Management Team and Supervisory Board with Key Appointments
6/30/2014 8:00:00 AM - GlobeNewswire

Prosensa Awarded $200,000 Research Grant from PPMD
6/27/2014 8:00:00 AM - GlobeNewswire

Prosensa Completes Enrollment in Natural History Study of Duchenne Muscular Dystrophy
6/25/2014 8:00:00 AM - GlobeNewswire

Prosensa's Hans Schikan Appointed to the Biotechnology Industry Organization's Emerging Companies Section Governing Board
6/23/2014 6:33:00 PM - GlobeNewswire

Prosensa to Present at the JMP Securities HealthCare Conference
6/19/2014 8:00:00 AM - GlobeNewswire

INSERTING and REPLACING CureDuchenne Media Statement Regarding Prosensa Announcement of Regulatory Path Forward for Drisapersen as a Potential Treatment for DMD
6/3/2014 10:44:00 AM - Business Wire

CureDuchenne Media Statement Regarding Prosensa Announcement of Regulatory Path Forward for Drisapersen as a Potential Treatment for DMD
6/3/2014 10:44:00 AM - Business Wire

Prosensa Announces Regulatory Path Forward for Drisapersen as a Potential Treatment for DMD
6/3/2014 7:00:00 AM - GlobeNewswire